A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 A Llevovist for Doppler enhancement in the portal system. - Gebel,M.; Caselitz,M.; Powen-Davies,P.; Weber,S. (Ultraschall in Med, 1998)